Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2011

Open Access 01-02-2011

TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors

Authors: Sudhanshu Agrawal, Sudhir Gupta

Published in: Journal of Clinical Immunology | Issue 1/2011

Login to get access

Abstract

Recently, it has been reported that using multiple signals, murine and human B cells secrete several cytokines with pro-inflammatory and immunoregulatory properties. We present the first comprehensive analysis of 24 cytokines, chemokines, and hematopoietic growth factors production by purified human peripheral blood B cells (CD19+), and naive (CD19+CD27-) and memory (CD19+CD27+) B cells in response to direct and exclusive signaling provided by toll-like receptor (TLR) ligands Pam3CSK (TLR1/TLR2), Imiquimod (TLR7), and GpG-ODN2006 (TLR9). All three TLR ligands stimulated B cells (CD19+) to produce cytokines IL-1α, IL-1β, IL-6, TNF-α, IL-13, and IL-10, and chemokines MIP-1α, MIP-1β, MCP-1, IP-10, and IL-8. However, GM-CSF and G-CSF production was predominantly induced by TLR2 agonist. Most cytokines/chemokines/hematopoietic growth factors were predominantly or exclusively produced by memory B cells, and in general, TLR2 signal was more powerful than signal provided viaTLR7 and TLR9. No significant secretion of eotaxin, IFN-α, IFN-γ, IL-2, IL-3, IL-4, IL-5, IL-7, IL-15, IL-17, IL-12p40, IL-12p70, and TNF-β (lymphotoxin) was observed. These data demonstrate that human B cells can be directly activated viaTLR1/TLR2, TLR7, and TLR9 to induce secretion of cytokines, chemokines, and hematopoietic growth factors and suggest a role of B cells in immune response against microbial pathogenesis and immune homeostasis.
Literature
1.
go back to reference Fillatreau S, Gray D, Anderson SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008;8:391–6.CrossRefPubMed Fillatreau S, Gray D, Anderson SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008;8:391–6.CrossRefPubMed
2.
go back to reference Hoehlig K, Lampropoulou V, Roch T, Neves P, Calderon-Gomez E, Anderton SM, et al. Immune regulation by B cells and antibodies a view towards the clinic. Adv Immunol. 2008;98:1–38.CrossRefPubMed Hoehlig K, Lampropoulou V, Roch T, Neves P, Calderon-Gomez E, Anderton SM, et al. Immune regulation by B cells and antibodies a view towards the clinic. Adv Immunol. 2008;98:1–38.CrossRefPubMed
3.
go back to reference Lund FE. Cytokine-producing B lymphocytes — key regulator of immunity. Curr Opin Immunol. 2008;20:332–8.CrossRefPubMed Lund FE. Cytokine-producing B lymphocytes — key regulator of immunity. Curr Opin Immunol. 2008;20:332–8.CrossRefPubMed
4.
go back to reference Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol. 2005;25:29–40.CrossRefPubMed Lenert P, Brummel R, Field EH, Ashman RF. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol. 2005;25:29–40.CrossRefPubMed
5.
go back to reference Bhan AK. A case for regulatory B cells. J Immunol. 2006;176:705–10.PubMed Bhan AK. A case for regulatory B cells. J Immunol. 2006;176:705–10.PubMed
6.
go back to reference Schultze JL, Michalak S, Lowne J, Wong A, Gilleece MH, Gribben JG, et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cells signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med. 1999;189:1–11.CrossRefPubMed Schultze JL, Michalak S, Lowne J, Wong A, Gilleece MH, Gribben JG, et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cells signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med. 1999;189:1–11.CrossRefPubMed
7.
go back to reference Barr TA, Brown S, Ryan G, Zhao J, Gray D. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur J Immunol. 2007;37:3040–53.CrossRefPubMed Barr TA, Brown S, Ryan G, Zhao J, Gray D. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur J Immunol. 2007;37:3040–53.CrossRefPubMed
9.
go back to reference Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol. 2006;36:810–6.CrossRefPubMed Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol. 2006;36:810–6.CrossRefPubMed
10.
go back to reference Duddy M, Niino M, Adatia F, Herbert S, Freedman M, Atkins H, et al. Distinct effector cytokine profile of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007;178:6092–9.PubMed Duddy M, Niino M, Adatia F, Herbert S, Freedman M, Atkins H, et al. Distinct effector cytokine profile of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol. 2007;178:6092–9.PubMed
11.
go back to reference Gargo A, Servis D, Cepika AM, Toellner KM, Grafton G, Taylor DR, et al. Type I cytokine profile of human naive and memory B lymphocytes: a potential for memory cells to impact polarization. Immunology. 2006;118:66–77.CrossRef Gargo A, Servis D, Cepika AM, Toellner KM, Grafton G, Taylor DR, et al. Type I cytokine profile of human naive and memory B lymphocytes: a potential for memory cells to impact polarization. Immunology. 2006;118:66–77.CrossRef
12.
go back to reference Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, et al. IL12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol. 2004;172:854–963. Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, et al. IL12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol. 2004;172:854–963.
13.
go back to reference Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann Rev Immunol. 2002;21:335–76.CrossRef Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann Rev Immunol. 2002;21:335–76.CrossRef
15.
go back to reference Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005;560:11–8.CrossRefPubMed Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005;560:11–8.CrossRefPubMed
16.
go back to reference Dasari P, Nicholson IC, Hodge G, Dandie GW, Zola H. Expression of toll-like receptors on B cells. Cell Immunol. 2005;236:140–5.CrossRefPubMed Dasari P, Nicholson IC, Hodge G, Dandie GW, Zola H. Expression of toll-like receptors on B cells. Cell Immunol. 2005;236:140–5.CrossRefPubMed
17.
go back to reference Mansson A, Adner M, Hockerfelt C, Cardell L-O. A distinct toll-like receptor repertoire in human tonsil B cells, directly activated by Pam3CSK4, R-837 and Cpg-200 stimuation. Immunology. 2006;118:539–48.PubMed Mansson A, Adner M, Hockerfelt C, Cardell L-O. A distinct toll-like receptor repertoire in human tonsil B cells, directly activated by Pam3CSK4, R-837 and Cpg-200 stimuation. Immunology. 2006;118:539–48.PubMed
18.
go back to reference Cognasse F, Hamzeh-Cogness H, Lafarge S, Chavarin P, Pozzeto B, Richard Y, et al. Identification of two subppulations of purified human Blood B cells, CD27–CD23+ and CD27highCD80+, that strongly express cell surface toll-like receptor 9 and secrete high levels of interleukin-6. Immunology. 2008;125:430–7.CrossRefPubMed Cognasse F, Hamzeh-Cogness H, Lafarge S, Chavarin P, Pozzeto B, Richard Y, et al. Identification of two subppulations of purified human Blood B cells, CD27–CD23+ and CD27highCD80+, that strongly express cell surface toll-like receptor 9 and secrete high levels of interleukin-6. Immunology. 2008;125:430–7.CrossRefPubMed
19.
go back to reference Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002;168:4531–7.PubMed Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002;168:4531–7.PubMed
20.
go back to reference Pistota V. Production of cytokines by human B cells in health and diseases. Immunol Today. 1997;18:343–50.CrossRef Pistota V. Production of cytokines by human B cells in health and diseases. Immunol Today. 1997;18:343–50.CrossRef
21.
go back to reference Krieg AM, Yi AK, Matson S, Waldscmidt TJ, Bishop GA, Teasdale R, et al. CpG motif in bacterial DNA trigger direct B cell activation. Nature. 1995;374:546–9.CrossRefPubMed Krieg AM, Yi AK, Matson S, Waldscmidt TJ, Bishop GA, Teasdale R, et al. CpG motif in bacterial DNA trigger direct B cell activation. Nature. 1995;374:546–9.CrossRefPubMed
22.
go back to reference Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol. 2007;37:2205–13.CrossRefPubMed Jiang W, Lederman MM, Harding CV, Rodriguez B, Mohner RJ, Sieg SF. TLR stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. Eur J Immunol. 2007;37:2205–13.CrossRefPubMed
23.
go back to reference Borsutzky S, Kreschmer K, Becker PD, Muhlradt PF, Kirsching CJ, Weiss S, et al. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J Immunol. 2005;174:6308–13.PubMed Borsutzky S, Kreschmer K, Becker PD, Muhlradt PF, Kirsching CJ, Weiss S, et al. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J Immunol. 2005;174:6308–13.PubMed
24.
go back to reference Bekeredjian-Ding I, Inamura S, Giese T, Moll H, Endres S, Sing A, et al. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J Immunol. 2007;178:2803–12.PubMed Bekeredjian-Ding I, Inamura S, Giese T, Moll H, Endres S, Sing A, et al. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J Immunol. 2007;178:2803–12.PubMed
25.
go back to reference Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol. 2005;174:4043–50.PubMed Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol. 2005;174:4043–50.PubMed
26.
go back to reference Booth JS, Griebel PJ, Babiuk LA, Mutwiri GK. A novel regulatory B-cell population in sheep Peyer’s patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses. Mucosal Immunol. 2009;2(3):265–75.CrossRefPubMed Booth JS, Griebel PJ, Babiuk LA, Mutwiri GK. A novel regulatory B-cell population in sheep Peyer’s patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses. Mucosal Immunol. 2009;2(3):265–75.CrossRefPubMed
27.
go back to reference Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19+CD24hiCD38hi exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32:129–40.CrossRefPubMed Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19+CD24hiCD38hi exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32:129–40.CrossRefPubMed
28.
go back to reference Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M. IFN-α amplifies human naive B cell TLR-9-mediated activation and Ig production. J Leukoc Biol. 2009;86:261–71.CrossRefPubMed Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M. IFN-α amplifies human naive B cell TLR-9-mediated activation and Ig production. J Leukoc Biol. 2009;86:261–71.CrossRefPubMed
29.
go back to reference Hanten JA, Vasilakos JP, Riter CI, Neys L, Lipson KE, Alkan SS, et al. Comparision of human B cell activation by TLR7 and TLR9. BMC Immunol. 2008;9:39.CrossRefPubMed Hanten JA, Vasilakos JP, Riter CI, Neys L, Lipson KE, Alkan SS, et al. Comparision of human B cell activation by TLR7 and TLR9. BMC Immunol. 2008;9:39.CrossRefPubMed
30.
go back to reference Zhang X, Deriaud E, Jiao X, Braun D, LeClerc C, Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin-10 producing B cells. J Exp Med. 2007;204:1107–18.CrossRefPubMed Zhang X, Deriaud E, Jiao X, Braun D, LeClerc C, Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin-10 producing B cells. J Exp Med. 2007;204:1107–18.CrossRefPubMed
31.
go back to reference Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987;166:1084–97.CrossRefPubMed Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987;166:1084–97.CrossRefPubMed
32.
go back to reference Lupardus PJ, Birnbaum ME, Garcia KC. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure. 2010;18:332–42.CrossRefPubMed Lupardus PJ, Birnbaum ME, Garcia KC. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure. 2010;18:332–42.CrossRefPubMed
33.
34.
go back to reference Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270:27348–57.CrossRefPubMed Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270:27348–57.CrossRefPubMed
35.
go back to reference Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein 1. Cytokine Growth Factor Rev. 2002;13:455–81.CrossRefPubMed Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein 1. Cytokine Growth Factor Rev. 2002;13:455–81.CrossRefPubMed
36.
go back to reference Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5:554–9.CrossRefPubMed Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol. 2009;5:554–9.CrossRefPubMed
Metadata
Title
TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors
Authors
Sudhanshu Agrawal
Sudhir Gupta
Publication date
01-02-2011
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2011
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9456-8

Other articles of this Issue 1/2011

Journal of Clinical Immunology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.